Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
2013
Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
2013
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
2013
Hepatocellular carcinoma
2016 Standout
Burden of liver diseases in the world
2018 Standout
Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis
2007
The cellular and molecular basis of hyperthermia
2002 Standout
Hepatitis B virus infection
2009 Standout
Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells
2008
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Combined Lamivudine and Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Recurrence after Liver Transplantation: Long‐Term Results
2003
Skin Cancers after Organ Transplantation
2003 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin
1997
Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B
2010
Management of Hepatocellular Carcinoma *
2005 Standout
Management of pediatric postrenal transplantation infections
2001
Cancer risk after renal transplantation in the nordic countries, 1964–1986
1995
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma
2015
Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species
2004
Hepatitis B reactivation after chemotherapy: two decades of clinical research
2008
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
2018 Standout
Living Liver Donor Mortality: Where Do We Stand?
2006
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Global burden of liver disease: 2023 update
2023 Standout
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
2020 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
2012 Standout
Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report
2004
Infection in Solid-Organ Transplant Recipients
2007 Standout
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance
2009
Evolution of Hepatitis B Virus Polymerase Gene Mutations in Hepatitis B E Antigen-Negative Patients Receiving Lamivudine Therapy
2000
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir
2013
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response
2007
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B
2001
Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice
2008 StandoutNobel
Eicosapentaenoic Acid Induces Fas-Mediated Apoptosis Through a p53-Dependent Pathway in Hepatoma Cells
2004
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
2020
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
2010
High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma
2008
The Three Es of Cancer Immunoediting
2004 Standout
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
2005
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B – a prospective cohort study with paired transient elastography examinations
2014
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
2011
Prevention of Hepatitis B Recurrence after Liver Transplantation
2005
MicroRNAs Transfer from Human Macrophages to Hepato-Carcinoma Cells and Inhibit Proliferation
2013
Works of A.K.K Chui being referenced
Complications of liver donation for living related liver transplantation
2004
Induction of Fas and Fas Ligand Expression on Malignant Glioma Cells by Kupffer Cells, a Potential Pathway of Antiliver Metastases
2001
Mutation of p53 in Recurrent Hepatocellular Carcinoma and Its Association with the Expression of ZBP-89
2003
Impact of severe acute respiratory syndrome on liver transplantation service
2004
Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu
1999
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation
2002
Outcome of lamivudine resistant hepatitis B virus mutant post‐liver transplantation on lamivudine monoprophylaxis
2004
Activation of Kupffer cells inhibits tumor growth in a murine model system
2002
Sensitivity of radiological investigations in diagnosing hepatocellular carcinoma in cirrhotic livers
2003
Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression.
1992